Human Papillomavirus Assays and Cytology in Primary Cervical Screening of Women Aged 30 Years and Above

In women aged ≥30 years, Human Papillomavirus testing will replace cytology for primary cervical screening. We compared Hybrid Capture 2 (HC2), cobas, CLART, and APTIMA HPV assays with cytology on 2869 SurePath samples from women undergoing routine screening at 30–65 years in Copenhagen, Denmark. Wo...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebolj, Matejka, Bonde, Jesper, Preisler, Sarah, Ejegod, Ditte, Rygaard, Carsten, Lynge, Elsebeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720421/
https://www.ncbi.nlm.nih.gov/pubmed/26789267
http://dx.doi.org/10.1371/journal.pone.0147326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720421/
https://www.ncbi.nlm.nih.gov/pubmed/26789267
http://dx.doi.org/10.1371/journal.pone.0147326

Ejemplares similares